Table 1.
Factors in patients with ovarian cancer.
| Characteristic | MSI | MSS | p-Value |
|---|---|---|---|
| n = 6 | n = 130 | ||
| Age: number (%) | 0.496 | ||
| <60 | 3 (50) | 54 (42) | |
| ≥60 | 3 (50) | 76 (58) | |
| FIGO Stage: number (%) | 0.357 | ||
| I, II | 3 (50) | 45 (35) | |
| III, IV | 3 (50) | 85 (65) | |
| Initial treatment (%) | 0.419 | ||
| PDS | 6 (100) | 112 (86) | |
| NAC | 0 (0) | 18 (14) | |
| Residual tumor after PDS or IDS (%) | 0.202 | ||
| No residual tumor (R0) | 4 (67) | 53 (41) | |
| Yes | 2 (33) | 77 (59) | |
MSI: microsatellite instability; MSS: microsatellite stable; FIGO: International Federation of Gynecology and Obstetrics; PDS: primary debulking surgery; NAC: neoadjuvant chemotherapy; IDS: interval debulking surgery.